Specific tandem duplications and fusions are important in detecting, prognostically scoring, and treating cancers (e.g. in AML, MLL PTDs[3]; FLT3 ITDs[4]; PML/RARA fusions[2]). This evidence concerns the gene FLT3 and acute myeloid leukemia.